Screener
Integra LifeSciences IART Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Goodwill impairment charge | — | 511,365 | — | 511,365 |
| Total costs and expenses | 399,476 | 928,279 | 779,924 | 1,326,429 |
| Operating income (loss) | 19,285 | (512,674) | 30,755 | (528,171) |
| Interest income | 4,267 | 4,710 | 8,372 | 9,130 |
| Interest expense | (22,994) | (21,042) | (45,459) | (39,857) |
| Other income (expense), net | 4,186 | (1,946) | 8,665 | (2,090) |
| Income (loss) before income taxes | 4,744 | (530,952) | 2,333 | (560,988) |
| Provision (benefit) for income taxes | 262 | (46,879) | 2,467 | (51,622) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's interest income?
- Integra LifeSciences (IART) reported interest income of $4.27M in Q2 2026.
- How has Integra LifeSciences's interest income changed year-over-year?
- Integra LifeSciences's interest income decreased by 9.4% year-over-year, from $4.71M to $4.27M.
- What is the long-term trend for Integra LifeSciences's interest income?
- Over 4 years (2021 to 2025), Integra LifeSciences's interest income has grown at a 28.7% compound annual growth rate (CAGR), from $6.74M to $18.47M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Integra LifeSciences's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude